New Jersey Bill Requires Automatic Enrollment in State Electronic Vaccine Tracking Registry
Lawmakers in New Jersey have approved legislation that would require enrollment in the state’s electronic vaccine tracking registry, unless citizens actively opt out in writing. The bill for an “opt-out” vaccine tracking system, rather than operating an “opt-in” system, comes in response to decreased vaccination rates in recent years and health officials maintain it will […]
Clinical Trials Now Required for Annual COVID Shots Given to Healthy Adults
On May 20, 2025, the U.S. Food and Drug Administration (FDA) announced that new clinical trials will be required to approve annual COVID-19 booster shots for healthy adults under age 65. In a joint editorial published in the New England Journal of Medicine, FDA commissioner Marty Makary, MD and the director of the FDA’s Center […]
Know the Risks of Rhogam and Vitamin K Shots Given to Pregnant Women and Newborn Babies
Pregnant mothers and newborn babies are routinely given a number of shots. Two controversial shots are Rhogam and vitamin K. Since the 1970’s, mothers-to-be whose blood work shows that they are Rh factor (Rhesus factor) negative are told to get a shot of Rh immunoglobulin (RhoGAM) during pregnancy, as well as after delivery if the […]
CDC Vaccine Advisory Panel Purged
On June 9, 2025, U.S. Secretary of Health and Human Services Robert F. Kennedy, Jr. fired all 17 members of the U.S. Centers for Disease Control and Prevention’s (CDC) committee that makes national vaccine policy—the Advisory Committee on Immunization Practices (ACIP). “A clean sweep is necessary to reestablish public confidence in vaccine science,” Secretary Kennedy […]
FDA Approves MenQuadfi Meningococcal Vaccine for Six-Week-Old Infants
The U.S. Food and Drug Administration (FDA) has licensed Sanofi’ SA’s four-valent MenQuadfi meningococcal vaccine for use in infants aged six weeks to 23 months old to prevent invasive meningococcal disease. Previously approved for children aged two and older, MenQuadfi is now the first meningococcal vaccine included on the U.S. Centers for Disease Control and […]
Government Cancels $700 Million in Funding for Moderna’s Bird Flu Biologic
The U.S. government has cancelled a contract worth over $700 million awarded to Moderna, Inc. for late-stage development of an mRNA bird flu biologic for humans, as well as the right to purchase the shots. Earlier this year, the Department of Health and Human Services (DHHS) Biomedical Advanced Research and Development Authority (BARDA) issued the […]